Expanding research applications: Ongoing studies continue to explore its role in cardiovascular risk reduction and long-term metabolic disease management
Translational nanomedicine potentiates immunotherapy in sarcoma by normalizing the microenvironment
F., Rodrigues de Freitas Junior, W., & Morato Toledo, L
Weight Loss: In the SURMOUNT-1 trial, after 72 weeks, the average weight loss was approximately 15.0% of body weight on 5 mg, 21.4% on 10 mg, and 22.5% on the maximum 15 mg dose
Smits MM, Tonneijck L, Muskiet MH, et al
In a 12-week study of adults with BMIs between 25 and 35, those taking 400 mg per day of Morosil lost nearly 7 pounds on average, compared to less than a pound in the placebo group